| 19.11.2024 09:24 | GSK | GSK hails positive results for linerixibat in treating relentless itch | Alliance |
| 18.11.2024 09:36 | PAY, OMU, SBRE | LONDON BROKER RATINGS: HSBC says 'buy' recruiters SThree and Hays | Alliance |
| 14.11.2024 08:54 | GSK | GSK hails survival results in blood cancer patients with Blenrep | Alliance |
| 14.11.2024 07:00 | GSK | GSK announces overall survival results for Blenrep | RNS |
| 13.11.2024 15:00 | GSK | Block listing Interim Review | RNS |
| 12.11.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.11.2024 09:35 | WHR, LABS, AIBG | LONDON BROKER RATINGS: Jefferies cuts Big Yellow, Shore cuts ITV | Alliance |
| 11.11.2024 15:01 | GSK | GSK publishes provisional 2025 dividend dates | RNS |
| 08.11.2024 09:39 | ASC, SFOR, SRC | LONDON BROKER RATINGS: Citigroup lifts Great Portland Estates to 'buy' | Alliance |
| 07.11.2024 16:24 | CCEP, AERI, HSD | UK dividends calendar - next 7 days | Alliance |
| 04.11.2024 16:16 | GOT, GSK, MTL | DIRECTOR DEALINGS: Drachs ups stake in Metals Exploration as CFO sells | Alliance |
| 01.11.2024 15:00 | GSK | Total Voting Rights | RNS |
| 01.11.2024 09:43 | LIO, SYNT, ASC | LONDON BROKER RATINGS: Deutsche cuts Smith & Nephew; Shore lifts Asos | Alliance |
| 31.10.2024 09:47 | EMG, CBG, BRBY | LONDON BROKER RATINGS: HSBC and Bernstein lift Burberry | Alliance |
| 30.10.2024 14:29 | GSK | Director/PDMR Shareholding | RNS |
| 30.10.2024 09:28 | GSK | TOP NEWS: GSK backs guidance despite third-quarter hit from Zantac | Alliance |
| 30.10.2024 07:00 | GSK | 3rd Quarter Results | RNS |
| 29.10.2024 12:48 | GSK | GSK inks deal to buy lupus therapy from Chimagen for USD300 million | Alliance |
| 24.10.2024 09:22 | GSK | IN BRIEF: GSK says Arexvy vaccine tests show wider potential for RSV | Alliance |
| 24.10.2024 07:00 | GSK | New positive Arexvy data in younger adults at risk | RNS |
| 23.10.2024 14:53 | STAN, SWR, NXT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 17.10.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 16.10.2024 16:09 | GSK | Director/PDMR Shareholding | RNS |
| 16.10.2024 08:33 | GSK | GSK's application for urinary tract infections drug is accepted | Alliance |
| 16.10.2024 07:00 | GSK | FDA accepts new drug application for gepotidacin | RNS |
| 14.10.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 14.10.2024 08:55 | GSK | TOP NEWS: GSK gets positive result from sinus disease treatment trials | Alliance |
| 14.10.2024 07:00 | GSK | Positive results of ANCHOR trials of depemokimab | RNS |
| 11.10.2024 15:33 | GSK | Director/PDMR Shareholding | RNS |
| 10.10.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 09.10.2024 19:59 | GSK | TOP NEWS: GSK to settle 80,000 Zantac cases for up to USD2.2 billion | Alliance |
| 09.10.2024 17:48 | GSK | Zantac (ranitidine) litigation settlements | RNS |
| 08.10.2024 13:18 | GSK | GSK trial proves RSV vaccine efficacy after three full seasons | Alliance |
| 08.10.2024 11:45 | GSK | Positive efficacy data of Arexvy over 3 seasons | RNS |
| 03.10.2024 15:45 | WPP, TSCO, SEC | UK dividends calendar - next 7 days | Alliance |
| 03.10.2024 09:39 | SFOR, OMU, MARS | LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating | Alliance |
| 01.10.2024 15:00 | GSK | Total Voting Rights | RNS |
| 01.10.2024 10:03 | GSK, HLN | UPDATE: Pfizer cuts stake in Haleon to 15% with GBP2.7 billion sale | Alliance |
| 01.10.2024 09:40 | CWR, ASC, KIST | LONDON BROKER RATINGS: Barclays cuts Smiths Group to 'equal weight' | Alliance |
| 30.09.2024 21:59 | GSK, HLN | TOP NEWS: Pfizer to raise around GBP2.7 billion from Haleon stake sale | Alliance |
| 24.09.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 24.09.2024 09:16 | GSK | TOP NEWS: GSK celebrates positive EU opinion of liquid Menveo vaccine | Alliance |
| 24.09.2024 07:00 | GSK | Positive EU opinion for GSK liquid Menveo vaccine | RNS |
| 18.09.2024 14:00 | GSK | GSK reaches further two settlements regarding Zantac | Alliance |
| 18.09.2024 13:20 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 17.09.2024 09:18 | GSK | GSK says Blenrep combinations accepted for review in Japan | Alliance |
| 17.09.2024 07:00 | GSK | Japan Filing Acceptance: Blenrep Multiple Myeloma | RNS |
| 13.09.2024 09:14 | GSK | GSK myeloma treatment given breakthrough therapy designation in China | Alliance |
| 12.09.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 12.09.2024 08:31 | GSK | TOP NEWS: GSK welcomes positive findings on possible flu treatment | Alliance |
| 12.09.2024 07:00 | GSK | Positive mRNA flu vaccine Phase II headline data | RNS |
| 11.09.2024 17:27 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 11.09.2024 15:30 | GSK | Change of Registered Office | RNS |
| 11.09.2024 09:55 | GSK | GSK stresses need for innovation as herpes vaccine fails to progress | Alliance |
| 11.09.2024 07:00 | GSK | Update on phase I/II therapeutic HSV vaccine trial | RNS |
| 09.09.2024 22:02 | CYAN, CLC, ENET | TRADING UPDATES: Live Co fails to reach agreement with creditor | Alliance |
| 09.09.2024 14:30 | GSK | Depemokimab late-breaking data presented at ERS | RNS |
| 06.09.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 06.09.2024 11:47 | GSK, OXB, IES | EXECUTIVE CHANGES: Invinity replaces CEO; Gulf Keystone chair dies | Alliance |
| 06.09.2024 09:38 | GSK | GSK hails positive results of Nucala clinical trials in lung disease | Alliance |
| 06.09.2024 07:00 | GSK | Positive Phase III results for Nucala in COPD | RNS |
| 02.09.2024 15:00 | GSK | Total Voting Rights | RNS |
| 29.08.2024 10:37 | GSK | TOP NEWS: GSK hails EU approval of RSV jab Arexy for 50-59 year olds | Alliance |
| 29.08.2024 07:00 | GSK | EMA approval on Arexvy for 50-59 at risk | RNS |
| 28.08.2024 09:14 | GSK | TOP NEWS: GSK hails approval in Japan; US court decision on Zantac | Alliance |
| 28.08.2024 07:10 | GSK | SENKU Designation for Bepirovirsen in Japan | RNS |
| 28.08.2024 07:05 | GSK | Nucala approved in Japan for use in CRSwNP | RNS |
| 28.08.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 21.08.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 20.08.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
| 20.08.2024 09:29 | GSK | TOP NEWS: GSK celebrates US FDA breakthrough therapy designation | Alliance |
| 20.08.2024 07:00 | GSK | B7-H3 ADC US FDA Breakthrough Therapy Designation | RNS |
| 16.08.2024 07:00 | GSK | TOP NEWS: GSK celebrates Florida state court ruling in Zantac case | Alliance |
| 16.08.2024 07:00 | GSK | Statement: Zantac (ranitidine) litigation | RNS |
| 12.08.2024 15:30 | GSK | Director/PDMR Shareholding | RNS |
